Skip to main content
2026 CRT Conference Main banner

CRT 2026

Innovation and Technology

Session:: CMO Roundtable [Non-CME]

Panel Discussion

Tuesday, March 10, 2026
12:45 PM - 1:00 PM EST
Location: International Ballroom Center

    Moderator(s)

  • Jeffrey J. Popma, MD

    Chief Scientific Officer
    CRF
    Newton, Massachusetts, United States

    Disclosure(s): Medtronic: CMO ended Nov 2024 (Terminated, November 1, 2024), Stock-publicly held company (excluding mutual/index funds) (Terminated, November 1, 2024)

  • Ron Waksman, MD, MSCAI

    Director, Cardiovascular Research and Advanced Education
    MedStar Washington Hospital Center, MedStar Heart and Vascular Institute
    Washington, District of Columbia, United States

    Disclosure information not submitted.

    • Panel Discussant(s)

  • Rafael Cavalcante, MD, PhD

    Vice President, Global Clinical
    Boston Scientific
    Newton, Massachusetts, United States

    Disclosure(s): Boston Scientific: Employee (Ongoing)

  • Kendra J. Grubb, MD

    VP/CMO Structural Heart
    Medtronic
    Atlanta, Georgia, United States

    Disclosure(s): Medtronic, Inc.: Employee (Ongoing)

  • Navin K. Kapur, MD, FSCAI FAHA FACC

    Professor of Medicine
    Tufts Medical Center
    Boston, Massachusetts, United States

    Disclosure information not submitted.

  • Duane Pinto, MD, MPH, FSCAI

    Chief Medical Officer
    JenaValve
    Boston, Massachusetts, United States

    Disclosure(s): AriaCV: Consulting Fees (e.g., advisory boards) (Ongoing); JenaValve Technology Inc: Employee (Ongoing); NupulseCV: BOD (Ongoing)

  • Mark Reisman, MD, FACC

    Director, Structural Heart Disease
    NYP Cornell
    new york , New York, United States

    Disclosure information not submitted.

  • Nick E. West, MA MD FRCP FESC FACC

    CMO
    Shockwave Medical
    Santa Clara, California, United States

    Disclosure information not submitted.

Disclosure(s):
Jeffrey J. Popma, MD: Medtronic: CMO ended Nov 2024 (Terminated, November 1, 2024), Stock-publicly held company (excluding mutual/index funds) (Terminated, November 1, 2024)
Rafael Cavalcante, MD, PhD: Boston Scientific: Employee (Ongoing)
Kendra J. Grubb, MD: Medtronic, Inc.: Employee (Ongoing)
Duane Pinto, MD, MPH, FSCAI: AriaCV: Consulting Fees (e.g., advisory boards) (Ongoing); JenaValve Technology Inc: Employee (Ongoing); NupulseCV: BOD (Ongoing)